Continual low-level MEK inhibition ameliorates cardio-facio-cutaneous phenotypes in zebrafish

by Corina Anastasaki, Katherine A. Rauen, E. Elizabeth Patton
Published 2012-07-01

Mutation analysis of BRAF, MEK1 and MEK2 in 15 ovarian cancer cell lines: implications for therapy.

by Anne L Estep, Chana Palmer, Frank McCormick, Katherine A Rauen
Published 2007-12-01

RASopathies: unraveling mechanisms with animal models

by Granton A. Jindal, Yogesh Goyal, Rebecca D. Burdine, Katherine A. Rauen, Stanislav Y. Shvartsman
Published 2015-08-01

RASopathies: unraveling mechanisms with animal models

by Granton A. Jindal, Yogesh Goyal, Rebecca D. Burdine, Katherine A. Rauen, Stanislav Y. Shvartsman
Published 2015-09-01

Reverse Pathway Genetic Approach Identifies Epistasis in Autism Spectrum Disorders.

by Ileena Mitra, Alinoë Lavillaureix, Erika Yeh, Michela Traglia, Kathryn Tsang, Carrie E Bearden, Katherine A Rauen, Lauren A Weiss
Published 2017-01-01

Autonomous and Non-autonomous Defects Underlie Hypertrophic Cardiomyopathy in BRAF-Mutant hiPSC-Derived Cardiomyocytes

by Rebecca Josowitz, Sonia Mulero-Navarro, Nelson A. Rodriguez, Christine Falce, Ninette Cohen, Erik M. Ullian, Lauren A. Weiss, Katherine A. Rauen, Eric A. Sobie, Bruce D. Gelb
Published 2016-09-01

Mek1Y130C mice recapitulate aspects of human cardio-facio-cutaneous syndrome

by Rifdat Aoidi, Nicolas Houde, Kim Landry-Truchon, Michael Holter, Kevin Jacquet, Louis Charron, Suguna Rani Krishnaswami, Benjamin D. Yu, Katherine A. Rauen, Nicolas Bisson, Jason Newbern, Jean Charron
Published 2018-03-01